Financial incentives for smoking cessation medication in european countries from the perspective of the angiology outpatient clinics

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F17%3A00099208" target="_blank" >RIV/00216224:14310/17:00099208 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Financial incentives for smoking cessation medication in european countries from the perspective of the angiology outpatient clinics

Popis výsledku v původním jazyce

There is a large disproportion in the access to the smoking cessation medication across European countries, with lower financial support in the eastern and central Europe. Majority of the European population suffers of limited access to the medication used for smoking cessation due to limited or no financial coverage by their health insurance companies. This gap is even bigger by restricted support for the prescriptions by vascular and other specialists.

Název v anglickém jazyce

Financial incentives for smoking cessation medication in european countries from the perspective of the angiology outpatient clinics

Popis výsledku anglicky

There is a large disproportion in the access to the smoking cessation medication across European countries, with lower financial support in the eastern and central Europe. Majority of the European population suffers of limited access to the medication used for smoking cessation due to limited or no financial coverage by their health insurance companies. This gap is even bigger by restricted support for the prescriptions by vascular and other specialists.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů